Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluMist concurrent with MMRII and VARIVAX in healthy children
NCT00192491Phase 3Completed
- Sponsor
- MedImmune
- Start
- Dec 2000
- Primary completion
- Sep 2003
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 3, randomised, double-blind trial of influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal) in influenza, measles, mumps and 2 more (3 arms), sponsored by MedImmune. Primary endpoint: Immune response to measles, mumps, rubella, and varicella antigens at Day 42. Started Dec 2000; status: completed.
02
Drugs
influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal)
03
Conditions
influenzameaslesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT00192491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192491.